CAMBREX PROFARMACO MILANO SRL
CAMBREX PROFARMACO MILANO SRL (Italy) holds 47 active US FDA Type II Drug Master Files and 20 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 1 FDA-registered manufacturing site. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “CAMBREX PROFARMACO MILANO SRL: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/cambrex-profarmaco-milano-srl
Overview
CAMBREX PROFARMACO MILANO SRL is an active pharmaceutical ingredient (API) supplier with 47 active FDA Type II Drug Master Files, covering ALBUTEROL / SALBUTAMOL SULPHATE; ALPRAZOLAM; AMIODARONE HCL; BISACODYL; CHLORDIAZEPOXIDE; CHLORDIAZEPOXIDE HYDROCHLORIDE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which CAMBREX PROFARMACO MILANO SRL holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
CAMBREX PROFARMACO MILANO SRL holds 47 active (67 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- MIRABEGRONActive2026-02-27
- DAPAGLIFLOZIN PROPYLENE GLYCOL MONOHYDRATEActive2025-07-23
- ELTROMBOPAG OLAMINEActive2024-07-25
- MIDAZOLAM HYDROCHLORIDEActive2024-06-11
- OLAPARIBActive2024-02-09
- MIDAZOLAM MALEATEActive2022-06-10
- MARAVIROCActive2020-11-18
- RIFAXIMINActive2016-11-04
- LACOSAMIDEActive2015-09-07
- CLOBAZAMActive2015-01-27
- EPINEPHRINE BITARTRATEActive2014-06-03
- CYSTEAMINE BITARTRATE (RP)Active2013-07-25
- EPINEPHRINEActive2012-04-13
- SODIUM PICOSULFATEActive2010-01-18
- RALOXIFENE HYDROCHLORIDEActive2009-07-07
- ZOLPIDEM TARTRATEActive2003-12-12
- LABETALOL HYDROCHLORIDEActive1997-11-24
- MIDAZOLAMActive1997-10-06
- SOTALOL HCLActive1996-12-17
- ESTAZOLAMActive1996-11-18
- NOREPINEPHRINE BITARTRATE/NORADRENALINE TARTRATEActive1996-07-10
- TERBUTALINE SULFATEActive1996-04-17
- CLOZAPINEActive1995-10-03
- CLONAZEPAMActive1995-02-17
- CYSTEAMINE BITARTRATEActive1992-09-30
- TRIAZOLAMActive1990-08-06
- CROMOLYN SODIUM / SODIUM CROMOGLICATEActive1989-08-02
- METAPROTERENOL SULFATEActive1989-07-10
- GLIPIZIDEActive1988-10-13
- GLYBURIDEActive1988-09-16
- ALPRAZOLAMActive1987-08-04
- DILTIAZEM HCLActive1987-01-05
- ALBUTEROL / SALBUTAMOL SULPHATEActive1986-08-07
- CHLORDIAZEPOXIDEActive1985-12-30
- LORAZEPAMActive1982-05-04
- OXAZEPAMActive1982-02-18
- METHYCLOTHIAZIDEActive1981-12-08
- TEMAZEPAMActive1981-11-12
- CLORAZEPATE DIPOTASSIUMActive1981-06-26
- LORMETAZEPAMActive1981-05-11
- AMIODARONE HCLActive1979-04-11
- FLURAZEPAM HYDROCHLORIDEActive1979-02-28
- BISACODYLActive1974-03-21
- DIAZEPAMActive1970-02-03
- CHLOROTHIAZIDEActive1965-03-18
- HYDROCHLOROTHIAZIDEActive1965-01-02
- CHLORDIAZEPOXIDE HYDROCHLORIDEActive1963-12-02
- NITAZOXANIDEInactive2016-12-06
- LamotrigineInactive2007-11-28
- QUETIAPINE FUMARATEInactive2007-10-22
Showing the 50 most relevant of 67 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to CAMBREX PROFARMACO MILANO SRL, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
1 FDA enforcement record linked to this company.
- warning_letter2009-08-12
FDA Warning Letter (drug product)
Is this CAMBREX PROFARMACO MILANO SRL?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.